Author

A.-N. Pelletier

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

R.-P. Sekaly· 2 shared A. M. Izmilry· 1 shared A. Metz· 1 shared B. Taramangalam· 1 shared E. A. Gordon· 1 shared E. K. Haddad· 1 shared E. Kallas· 1 shared G. K. Tharp· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

R.-P. Sekaly

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single cell analysis reveals an antiviral network that controls Zika virus infection in human dendritic cells

K. M. Moore, A.-N. Pelletier, S. Lapp, A. Metz, G. K. Tharp, M. Lee, S. S. Bhasin, M. Bhasin, R.-P. Sekaly, S. E. Bosinger, M. S. Suthar

The paper uses scRNA-seq to analyze the antiviral response in human dendritic cells infected with ZIKV, identifying a network of host genes and proteins involved in antiviral defense.

bioRxiv · Jan 19, 2024Microbiology

Pre-vaccination Frequency of Circulatory Tfh is associated with Robust Immune Response to TV003 Dengue Vaccine

A. M. Izmilry, A.-N. Pelletier, J. Connors, B. Taramangalam, S. O. Alturki, E. A. Gordon, S. O. Alturki, J. C. Mell, G. Swaminathan, V. Karthik, M. A. Kutzler, E. Kallas, R.-P. Sekaly, E. K. Haddad

This study finds that pre-vaccination levels of circulating Tfh cells and CXCL13/BLC correlate with robust neutralizing antibody responses to the TV003 Dengue vaccine in seropositive individuals.

bioRxiv · Aug 19, 2021Immunology